Pharma Mar SAU(PMRA) News

Date	Title
Oct 16	High Growth Tech Highlights Three Promising Stocks
Oct 15	PharmaMar Announces Positive and Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca® (lurbinectedin) and Atezolizumab Combination in First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer